Onboarding Experience of Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin 10%.

Details

Language :

English

ISSN :

00916749

Volume :

141

Database :

Supplemental Index

Journal :

Journal of Allergy & Clinical Immunology

Publication Type :

Academic Journal

Accession number :

128586611

Full Text :

https://doi.org/10.1016/j.jaci.2017.12.081